Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation. / van der Velden, Rachel M. J.; Pluymaekers, Nikki A. H. A.; Dudink, Elton A. M. P.; Luermans, Justin G. L. M.; Meeder, Joan G.; Heesen, Wilfred F.; Lenderink, Timo; Widdershoven, Jos W. M. G.; Bucx, Jeroen J. J.; Rienstra, Michiel; Kamp, Otto; van Opstal, Jurren M.; Kirchhof, Charles J. H. J.; van Dijk, Vincent F.; Swart, Henk P.; Alings, Marco; Van Gelder, Isabelle C.; Crijns, Harry J. G. M.; Linz, Dominik.

In: Heart, Vol. 109, No. 1, 2022, p. 26–33.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

van der Velden, RMJ, Pluymaekers, NAHA, Dudink, EAMP, Luermans, JGLM, Meeder, JG, Heesen, WF, Lenderink, T, Widdershoven, JWMG, Bucx, JJJ, Rienstra, M, Kamp, O, van Opstal, JM, Kirchhof, CJHJ, van Dijk, VF, Swart, HP, Alings, M, Van Gelder, IC, Crijns, HJGM & Linz, D 2022, 'Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation', Heart, vol. 109, no. 1, pp. 26–33. https://doi.org/10.1136/heartjnl-2022-321346

APA

van der Velden, R. M. J., Pluymaekers, N. A. H. A., Dudink, E. A. M. P., Luermans, J. G. L. M., Meeder, J. G., Heesen, W. F., Lenderink, T., Widdershoven, J. W. M. G., Bucx, J. J. J., Rienstra, M., Kamp, O., van Opstal, J. M., Kirchhof, C. J. H. J., van Dijk, V. F., Swart, H. P., Alings, M., Van Gelder, I. C., Crijns, H. J. G. M., & Linz, D. (2022). Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation. Heart, 109(1), 26–33. https://doi.org/10.1136/heartjnl-2022-321346

Vancouver

van der Velden RMJ, Pluymaekers NAHA, Dudink EAMP, Luermans JGLM, Meeder JG, Heesen WF et al. Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation. Heart. 2022;109(1):26–33. https://doi.org/10.1136/heartjnl-2022-321346

Author

van der Velden, Rachel M. J. ; Pluymaekers, Nikki A. H. A. ; Dudink, Elton A. M. P. ; Luermans, Justin G. L. M. ; Meeder, Joan G. ; Heesen, Wilfred F. ; Lenderink, Timo ; Widdershoven, Jos W. M. G. ; Bucx, Jeroen J. J. ; Rienstra, Michiel ; Kamp, Otto ; van Opstal, Jurren M. ; Kirchhof, Charles J. H. J. ; van Dijk, Vincent F. ; Swart, Henk P. ; Alings, Marco ; Van Gelder, Isabelle C. ; Crijns, Harry J. G. M. ; Linz, Dominik. / Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation. In: Heart. 2022 ; Vol. 109, No. 1. pp. 26–33.

Bibtex

@article{8346d0127a4c4ccba4d7912c2af39aee,
title = "Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation",
abstract = "Objective The Rate Control versus Electrical Cardioversion Trial 7-Acute Cardioversion versus Wait and See trial compared early to delayed cardioversion for patients with recent-onset symptomatic atrial fibrillation (AF). This study aims to evaluate the adherence to a 4-week mobile health (mHealth) prescription to detect AF recurrences after an emergency department visit.Methods After the emergency department visit, the 437 included patients, irrespective of randomisation arm (early or delayed cardioversion), were asked to record heart rate and rhythm for 1 min three times daily and in case of symptoms by an electrocardiography-based handheld device for 4 weeks (if available). Adherence was appraised as number of performed measurements per number of recordings asked from the patient and was evaluated for longitudinal adherence consistency. All patients who used the handheld device were included in this subanalysis.Results 335 patients (58% males; median age 67 (IQR 11) years) were included. The median overall adherence of all patients was 83.3% (IQR 29.9%). The median number of monitoring days was 27 out of 27 (IQR 5), whereas the median number of full monitoring days was 16 out of 27 (IQR 14). Higher age and a previous paroxysm of AF were identified as multivariable adjusted factors associated with adherence.Conclusions In this randomised trial, a 4-week mHealth prescription to monitor for AF recurrences after an emergency department visit for recent-onset AF was feasible with 85.7% of patients consistently using the device with at least one measurement per day. Older patients were more adherent.",
keywords = "RHYTHM, CARDIOVERSION",
author = "{van der Velden}, {Rachel M. J.} and Pluymaekers, {Nikki A. H. A.} and Dudink, {Elton A. M. P.} and Luermans, {Justin G. L. M.} and Meeder, {Joan G.} and Heesen, {Wilfred F.} and Timo Lenderink and Widdershoven, {Jos W. M. G.} and Bucx, {Jeroen J. J.} and Michiel Rienstra and Otto Kamp and {van Opstal}, {Jurren M.} and Kirchhof, {Charles J. H. J.} and {van Dijk}, {Vincent F.} and Swart, {Henk P.} and Marco Alings and {Van Gelder}, {Isabelle C.} and Crijns, {Harry J. G. M.} and Dominik Linz",
year = "2022",
doi = "10.1136/heartjnl-2022-321346",
language = "English",
volume = "109",
pages = "26–33",
journal = "Heart",
issn = "1355-6037",
publisher = "B M J Group",
number = "1",

}

RIS

TY - JOUR

T1 - Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation

AU - van der Velden, Rachel M. J.

AU - Pluymaekers, Nikki A. H. A.

AU - Dudink, Elton A. M. P.

AU - Luermans, Justin G. L. M.

AU - Meeder, Joan G.

AU - Heesen, Wilfred F.

AU - Lenderink, Timo

AU - Widdershoven, Jos W. M. G.

AU - Bucx, Jeroen J. J.

AU - Rienstra, Michiel

AU - Kamp, Otto

AU - van Opstal, Jurren M.

AU - Kirchhof, Charles J. H. J.

AU - van Dijk, Vincent F.

AU - Swart, Henk P.

AU - Alings, Marco

AU - Van Gelder, Isabelle C.

AU - Crijns, Harry J. G. M.

AU - Linz, Dominik

PY - 2022

Y1 - 2022

N2 - Objective The Rate Control versus Electrical Cardioversion Trial 7-Acute Cardioversion versus Wait and See trial compared early to delayed cardioversion for patients with recent-onset symptomatic atrial fibrillation (AF). This study aims to evaluate the adherence to a 4-week mobile health (mHealth) prescription to detect AF recurrences after an emergency department visit.Methods After the emergency department visit, the 437 included patients, irrespective of randomisation arm (early or delayed cardioversion), were asked to record heart rate and rhythm for 1 min three times daily and in case of symptoms by an electrocardiography-based handheld device for 4 weeks (if available). Adherence was appraised as number of performed measurements per number of recordings asked from the patient and was evaluated for longitudinal adherence consistency. All patients who used the handheld device were included in this subanalysis.Results 335 patients (58% males; median age 67 (IQR 11) years) were included. The median overall adherence of all patients was 83.3% (IQR 29.9%). The median number of monitoring days was 27 out of 27 (IQR 5), whereas the median number of full monitoring days was 16 out of 27 (IQR 14). Higher age and a previous paroxysm of AF were identified as multivariable adjusted factors associated with adherence.Conclusions In this randomised trial, a 4-week mHealth prescription to monitor for AF recurrences after an emergency department visit for recent-onset AF was feasible with 85.7% of patients consistently using the device with at least one measurement per day. Older patients were more adherent.

AB - Objective The Rate Control versus Electrical Cardioversion Trial 7-Acute Cardioversion versus Wait and See trial compared early to delayed cardioversion for patients with recent-onset symptomatic atrial fibrillation (AF). This study aims to evaluate the adherence to a 4-week mobile health (mHealth) prescription to detect AF recurrences after an emergency department visit.Methods After the emergency department visit, the 437 included patients, irrespective of randomisation arm (early or delayed cardioversion), were asked to record heart rate and rhythm for 1 min three times daily and in case of symptoms by an electrocardiography-based handheld device for 4 weeks (if available). Adherence was appraised as number of performed measurements per number of recordings asked from the patient and was evaluated for longitudinal adherence consistency. All patients who used the handheld device were included in this subanalysis.Results 335 patients (58% males; median age 67 (IQR 11) years) were included. The median overall adherence of all patients was 83.3% (IQR 29.9%). The median number of monitoring days was 27 out of 27 (IQR 5), whereas the median number of full monitoring days was 16 out of 27 (IQR 14). Higher age and a previous paroxysm of AF were identified as multivariable adjusted factors associated with adherence.Conclusions In this randomised trial, a 4-week mHealth prescription to monitor for AF recurrences after an emergency department visit for recent-onset AF was feasible with 85.7% of patients consistently using the device with at least one measurement per day. Older patients were more adherent.

KW - RHYTHM

KW - CARDIOVERSION

U2 - 10.1136/heartjnl-2022-321346

DO - 10.1136/heartjnl-2022-321346

M3 - Journal article

C2 - 36322782

VL - 109

SP - 26

EP - 33

JO - Heart

JF - Heart

SN - 1355-6037

IS - 1

ER -

ID: 319255274